Dan Rose is the founder of Endovascular Engineering. Endovascular Engineering has raised $137M in total funding. Latest round: Series C.
Dan Rose is the founder of Endovascular Engineering (E2), a California-based medtech company. He announced the company's Series B and Series C funding rounds to advance commercialization of its thrombectomy platform for pulmonary embolism treatment. Rose leads the team through clinical trials and toward FDA submission and market launch.
Full founder directory · Investor directory · Company funding database · Fundraising library